Circulating HLA-G and its association with cardiovascular markers in pregnancy

J Reprod Immunol. 2021 Aug:146:103331. doi: 10.1016/j.jri.2021.103331. Epub 2021 May 19.

Abstract

Human Leukocyte Antigen-G (HLA-G) prevents the activity of immune cells and is decreased in women with preeclampsia. We aimed to investigate the associations between circulating soluble HLA-G (sHLA-G) and 92 cardiovascular disease-related biomarkers from a previously published multiplex study in women with preeclampsia and controls. We found 15 markers significantly associated with circulating sHLA-G in univariate analyses. After multivariable adjusted regression, only proto-oncogene tyrosine-protein kinase Src (SRC) and vascular endothelial growth factor D were significantly associated with sHLA-G. Low SRC, previously observed in the circulation of preeclamptic women, may be regulated by low sHLA-G, and reflect decreased trophoblast differentiation and syncytical formation.

Keywords: CVD; Multiplex; Preeclampsia; SRC; VEGFD.

Publication types

  • Observational Study

MeSH terms

  • Biomarkers / blood
  • Case-Control Studies
  • Cell Differentiation / immunology
  • Cesarean Section
  • Female
  • HLA-G Antigens / blood*
  • HLA-G Antigens / immunology
  • Heart Disease Risk Factors
  • Humans
  • Pre-Eclampsia / blood
  • Pre-Eclampsia / diagnosis
  • Pre-Eclampsia / epidemiology*
  • Pre-Eclampsia / immunology
  • Pregnancy
  • Risk Assessment / methods
  • Trophoblasts / immunology*
  • Vascular Endothelial Growth Factor D / blood
  • src-Family Kinases / blood

Substances

  • Biomarkers
  • HLA-G Antigens
  • VEGFD protein, human
  • Vascular Endothelial Growth Factor D
  • src-Family Kinases